These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17437289)

  • 1. Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.
    Tanoshima R; Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
    Pediatr Blood Cancer; 2008 Mar; 50(3):665-7. PubMed ID: 17437289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappearance of minimal residual disease after the early withdrawal of immunosuppressants in a patient with juvenile myelomonocytic leukemia.
    Yanagisawa R; Matsuda K; Sakashita K; Nakazawa Y; Tanaka M; Saito S; Yoshikawa K; Kamijo T; Shiohara M; Koike K
    Pediatr Blood Cancer; 2011 Mar; 56(3):501-2. PubMed ID: 21225940
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant.
    Okada H; Nomi K; Hamatani S; Kuromi T; Nanba M; Imai T; Isobe K; Itoh S
    Bone Marrow Transplant; 2002 Oct; 30(7):463-5. PubMed ID: 12368960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
    Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
    Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of T-cell acute lymphoblastic leukemia in a patient in very long lasting complete remission of juvenile myelomonocytic leukemia.
    Maschan AA; Khachatrian LA; Solopova GG; Ossipova EY; Baidun LV; Dmitrieva SV; Maschan MA; Resnik IB
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e32-4. PubMed ID: 21102353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
    Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Yabe M; Sako M; Yabe H; Osugi Y; Kurosawa H; Nara T; Tokuyama M; Adachi S; Kobayashi C; Yanagimachi M; Ohtsuka Y; Nakazawa Y; Ogawa C; Manabe A; Kojima S; Nakahata T;
    Pediatr Transplant; 2008 Dec; 12(8):862-7. PubMed ID: 18397212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia.
    Orchard PJ; Miller JS; McGlennen R; Davies SM; Ramsay NK
    Bone Marrow Transplant; 1998 Jul; 22(2):201-3. PubMed ID: 9707031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
    Miyakoshi S; Kami M; Tanimoto T; Yamaguchi T; Narimatsu H; Kusumi E; Matsumura T; Takagi S; Kato D; Kishi Y; Murashige N; Yuji K; Uchida N; Masuoka K; Wake A; Taniguchi S
    Transplantation; 2007 Aug; 84(3):316-22. PubMed ID: 17700155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term remission in an acute monoblastic leukemia patient with down syndrome after cord blood transplantation].
    Kurosawa H; Tsuboi T; Shimaoka H; Okuya M; Nakajima D; Matsunaga T; Hagisawa S; Sato Y; Sugita K; Eguchi M
    Rinsho Ketsueki; 2005 Apr; 46(4):274-7. PubMed ID: 16444960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML).
    Neudorf S; Nourani A; Kempert P; Shen V; Sender L; Kirov I
    Bone Marrow Transplant; 2004 May; 33(10):1069. PubMed ID: 15064688
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
    Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
    Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML.
    Pulsipher MA; Adams RH; Asch J; Petersen FB
    Bone Marrow Transplant; 2004 Jan; 33(1):113-5. PubMed ID: 14704663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha.
    Ohta H; Kawai M; Sawada A; Tokimasa S; Fujisaki H; Matsuda Y; Osugi Y; Okada S; Hara J
    Bone Marrow Transplant; 2000 Sep; 26(6):681-3. PubMed ID: 11041570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.